Katherine C. Fuh, MD, PhD
Research Physician, MD
Washington University School of Medicine
660 S Euclid Ave
St Louis,
MO
USA
63110
Papers:
9
Differences in presentation and survival of Asians versus Caucasians with ovarian cancer: a Gynecologic Oncology Group ancillary study of 7,914 patients
105
Comparison of dose-dense and every-3-week taxane in the neoadjuvant treatment of ovarian, fallopian tube, and primary peritoneal cancer
128
Disease stabilization vs. response after bevacizumab treatment in recurrent ovarian cancer: how do we determine clinical efficacy?
137
The metastatic role of AXL, a receptor tyrosine kinase, in a genetically engineered mouse model of metastatic, endometrioid ovarian cancer
245
Gyn/Onc partnership with sarcoma center yields superior clinical trial enrollments for uterine leiomyosarcoma patients